Financial giants have made a conspicuous bearish move on Paychex. Our analysis of options history for Paychex (NASDAQ:PAYX) revealed 10 unusual trades.Delving into the details, we found 30% of traders were bullish, while 60% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $179,340, and 6 were calls, valued at $250,240.What's The Price Target?After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band ...

Investors might want to bet on Curtiss-Wright (CW) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual inve ...

Financial giants have made a conspicuous bullish move on Freeport-McMoRan. Our analysis of options history for Freeport-McMoRan (NYSE:FCX) revealed 38 unusual trades.Delving into the details, we found 65% of traders were bullish, while 15% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $126,403, and 35 were calls, valued at $2,771,600.Expected Price MovementsAfter evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusi ...

Palisade Bio, Inc. (PALI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a c ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for momentum i ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Ondas Holdings.Looking at options history for Ondas Holdings (NASDAQ:ONDS) we detected 28 trades.If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 35% with bearish.From the overall spotted trades, 2 are puts, for a total amount of $223,000 and 26, calls, for a total amount of $1,663,914.Projected Price TargetsBased on the trading activity, it a ...

Symrise AG Unsponsored ADR (SYIEY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a ch ...

In the current session, the stock is trading at $16.15, after a 1.32% spike. Over the past month, UiPath Inc. (NYSE:PATH) stock increased by 24.25%, and in the past year, by 23.87%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Comparing UiPath P/E Against Its PeersThe P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the ...

Core Viewpoint - Assurant, Inc. is a global provider of risk management solutions, focusing on housing and lifestyle markets, and competes with other firms in the insurance and risk management sector [1] Group 1: Analyst Ratings and Price Targets - Piper Sandler maintains an "Overweight" rating for Assurant, raising its price target from $252 to $264, indicating confidence in the company's future performance [2][6] - Assurant has received an average recommendation of "Moderate Buy" from ten research firms, with eight analysts recommending buying the stock and two suggesting holding it, reflecting general optimism [3][6] - Truist Financial set a price objective of $255 for Assurant, while UBS Group raised their price target from $255 to $257, maintaining a "buy" rating [4] Group 2: Stock Performance and Market Capitalization - Assurant's stock is currently priced at $238.03, with a slight increase of 0.42%, and has fluctuated between $234.66 and $240.58 today [5][6] - The stock's year-high is $240.58, and the lowest price over the past year was $174.97, indicating significant price movement [5] - Assurant's market capitalization is approximately $11.92 billion, with a trading volume of 305,710 shares today [5][6]

Sales of previously occupied U.S. homes rose in November from the previous month, but slowed compared to a year earlier for the first time since May despite average long-term mortgage rates holding near their low point for the year. Through the first 11 months of this year, home sales are down 0.5% compared to the same period last year. Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters "It's possible that 2025, unless Decem ...